Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate for Breast Cancer Prevention
NCT02408770Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jan 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ulipristal in breast cancer, sponsored by Manchester University NHS Foundation Trust. Started Jan 2016; status: completed.
02
Drugs
ulipristal
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02408770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408770.